Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry. | Nat Commun | 2025 | 41038821 | PubTator, text mining | PubMed |
| Theory of clinical therapeutic progress: reconciling equipoise with fat-tailed (skewed) outcomes. | J Clin Epidemiol | 2025 | 41033405 | PubTator, text mining | PubMed |
| Targeting FAK to Potentiate Immune Checkpoint Therapy in Solid Tumors. | J Cancer Immunol (Wilmington) | 2025 | 41019359 | PubTator, text mining | PubMed |
| MSRS-DETR: End-to-End Object Detection for Multi-Scale Remote Sensing. | Sensors (Basel) | 2025 | 41012971 | PubTator, text mining | PubMed |
| Integrative Mutational Landscape of Mycosis Fungoides Using a National Genomics Repository. | Cancers (Basel) | 2025 | 41008827 | PubTator, text mining | PubMed |
| Fatty Acid Profile and Desaturase Activity in Obesity: Roles, Mechanisms, and Clinical Relevance. | Metabolites | 2025 | 41002979 | PubTator, text mining | PubMed |
| Comparison of Metabolic and Pulmonary Variables Between Real-Life and Mixed Reality Pickleball. | J Funct Morphol Kinesiol | 2025 | 40981045 | PubTator, text mining | PubMed |
| Homozygous FAT1 frameshift mutation linked to glomerulotubular nephropathy with impaired cell adhesion and Rap1 signaling. | Ren Fail | 2025 | 40976965 | PubTator, text mining | PubMed |
| Prognosis and Failure Patterns of 11q13 Amplified Local Advanced Squamous Cell Carcinoma of the Head and Neck. | Cancer Med | 2025 | 40974176 | PubTator, text mining | PubMed |
| Identifying predictive markers of head and neck squamous cell carcinoma in an umbrella trial (KCSG HN 15-16 TRIUMPH trial). | ESMO Open | 2025 | 40967067 | PubTator, text mining | PubMed |
| EGFR Mutation Detection in Whole Slide Images of Non-Small Cell Lung Cancers Using a Two-Stage Deep Transfer Learning Approach. | Cancer Med | 2025 | 40965349 | PubTator, text mining | PubMed |
| The Clinical Relevance of FTO as a Demethylase Beyond Cancer: Molecular Mechanisms and Therapeutic Opportunities. | Aging Dis | 2025 | 40956960 | PubTator, text mining | PubMed |
| Tumour Single-Cell Bioinformatics: From Immune Profiling to Molecular Dynamics. | J Cell Mol Med | 2025 | 40954554 | PubTator, text mining | PubMed |
| Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical Outcomes. | medRxiv | 2025 | 40950448 | PubTator, text mining | PubMed |
| Spatial colocalization and molecular crosstalk of myofibroblastic CAFs and tumor cells shape lymph node metastasis in oral squamous cell carcinoma. | PLoS Genet | 2025 | 40906645 | PubTator, text mining | PubMed |
| Atypical cadherin FAT1 promotes tumorigenesis by suppressing autophagic cell death in glioblastoma under hypoxia or nutrient stress. | Cell Mol Biol Lett | 2025 | 40903775 | PubTator, text mining | PubMed |
| Association of Exercise and Dietary Habits With Muscle and Fat Mass in Healthy Working-Age Adults: A Cross-Sectional Study. | Cureus | 2025 | 40896000 | PubTator, text mining | PubMed |
| Identification of biomarkers based on ubiquitin-correlated genes for predicting immune profile and drug sensitivity in lung adenocarcinoma. | Front Pharmacol | 2025 | 40894221 | PubTator, text mining | PubMed |
| Profiling Protein Post-Translational Modifications in Plasma-derived Extracellular Vesicles as Fingerprints for Breast Cancer Subtypes. | Res Sq | 2025 | 40894036 | PubTator, text mining | PubMed |
| A predictive model for evaluating the efficacy of immunotherapy in non-small-cell lung cancer patients: A real-world study. | J Int Med Res | 2025 | 40891808 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=9